CareDx applauds HHS Report on Cost Savings of Lifetime Immunosuppressive Drug Coverage for Transplant Patients
“The analysis is potentially game changing for the prospects of the bill’s passage. The cost associated with this change has thwarted its passage in the past. Assuming the Congressional Budget Office can agree with ASPE’s analytical assumptions, a cost-saving bill could easily be included in legislative packages moving forward,” said
Learn more about CareDx’s work to extend
For more information, please visit: www.CareDx.com.
Forward Looking Statements
This press release includes forward-looking statements, including statements regarding the Company’s participation in the Honor the Gift campaign. These forward-looking statements are based upon information that is currently available to
Chief Commercial Officer
Integrated Corporate Relations, Inc.
Source: CareDx, Inc.